First Time Loading...

WuXi Biologics (Cayman) Inc
HKEX:2269

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
HKEX:2269
Watchlist
Price: 13.96 HKD -4.12% Market Closed
Updated: May 4, 2024

WuXi Biologics (Cayman) Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

WuXi Biologics (Cayman) Inc
Cash from Operating Activities Peer Comparison

Comparables:
603259
300759
300347
1548
M
688114

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
WuXi Biologics (Cayman) Inc
HKEX:2269
Cash from Operating Activities
¥6.8B
CAGR 3-Years
54%
CAGR 5-Years
55%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Cash from Operating Activities
¥13.4B
CAGR 3-Years
50%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Cash from Operating Activities
¥2.8B
CAGR 3-Years
19%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Cash from Operating Activities
¥1.2B
CAGR 3-Years
5%
CAGR 5-Years
17%
CAGR 10-Years
31%
Genscript Biotech Corp
HKEX:1548
Cash from Operating Activities
-$245.5m
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
MGI Tech Co Ltd
SSE:688114
Cash from Operating Activities
¥1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is WuXi Biologics (Cayman) Inc's Cash from Operating Activities?
Cash from Operating Activities
6.8B CNY

Based on the financial report for Dec 31, 2023, WuXi Biologics (Cayman) Inc's Cash from Operating Activities amounts to 6.8B CNY.

What is WuXi Biologics (Cayman) Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
55%

Over the last year, the Cash from Operating Activities growth was 23%. The average annual Cash from Operating Activities growth rates for WuXi Biologics (Cayman) Inc have been 54% over the past three years , 55% over the past five years .